ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Michell et al. demonstrated the genetic or pharmacological inhibition of mTOR, and therefore, autophagy primed BCR::ABL1-independent ponatinib-resistant CML cells to the mTOR inhibitor and induced apoptosis [70].